Skip to content
Feb 1, 2022

Martin Shkreli, former CEO of Vyera Pharmaceuticals, has been ordered by a court to return almost $65 million in profits that he and his company made from monopolizing the market for the lifesaving drug Daraprim. The anti-parasite drug is used to prevent and treat parasitic infections from the Toxoplasma gondii parasite as well as malaria, and Shkreli played a pivotal role in leading the company's fight against generic competitors while he was in prison.
  • 6 minutes


Want to put your two cents in? We want to hear it! Posting comments is only available for TYT members in good standing.

Click here to learn more about becoming a TYT member.


New page: The Young Turks 2022-02-01 -